McKesson Corporation $MCK Stock: Plancorp LLC Grows Position

Plancorp LLC boosted its holdings in McKesson Corporation (NYSE:MCK) by 74.6% during the third quarter, Holdings Channel reports. The institutional investor owned 1,557 shares of the company’s stock after buying an additional 665 shares during the period. Plancorp LLC’s holdings in McKesson were worth $1,329,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in MCK. Nvwm LLC increased its stake in shares of McKesson by 933.3% during the 3rd quarter. Nvwm LLC now owns 31 shares of the company’s stock valued at $26,000 after acquiring an additional 28 shares during the last quarter. Delos Wealth Advisors LLC purchased a new position in shares of McKesson during the 2nd quarter worth about $27,000. Trellis Wealth Advisors LLC acquired a new stake in shares of McKesson in the third quarter worth approximately $32,000. Clearstead Trust LLC acquired a new stake in shares of McKesson in the second quarter worth approximately $37,000. Finally, GK Wealth Management LLC purchased a new stake in McKesson in the third quarter valued at approximately $38,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Key McKesson News

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson beat fiscal Q2 2027 estimates, reporting adjusted EPS of $11.68 and revenue of about $111 billion, up roughly 7.5% year over year. The company also raised its fiscal 2027 adjusted EPS outlook to $45.60–$46.40, supported by specialty-drug demand, higher prescription volumes and operating gains. MCK Q2 Earnings Beat Estimates on Specialty Growth, Outlook Raised
• Positive Sentiment: Analyst sentiment has strengthened: UBS raised its price target to $1,250 and maintained a Buy rating, while TD Cowen and Leerink Partners lifted targets to $1,200. Separately, Zacks upgraded MCK to Rank #2 (Buy), citing improving earnings prospects. Zacks upgrades McKesson to Buy
• Neutral Sentiment: EVP Francisco Fraga sold 650 shares under a pre-arranged Rule 10b5-1 plan and retained 4,414 shares. The filing does not explain the purpose of this latest sale; an earlier sale was described as covering tax withholding on vested equity awards. SEC filing
• Negative Sentiment: RBC raised its price target but kept a Sector Perform rating and set a $965 target, below the recent share price. That more cautious view may temper enthusiasm after MCK’s strong run. RBC comments on McKesson’s execution

Analyst Ratings Changes

MCK has been the subject of several research analyst reports. Leerink Partners upped their price target on shares of McKesson from $1,070.00 to $1,200.00 and gave the stock an “outperform” rating in a research report on Thursday. Evercore reiterated an “outperform” rating and issued a $950.00 price target (down from $1,000.00) on shares of McKesson in a report on Thursday, August 6th. Mizuho boosted their price objective on shares of McKesson from $905.00 to $1,020.00 and gave the company a “neutral” rating in a research note on Tuesday, October 20th. Morgan Stanley set a $977.00 price objective on McKesson in a report on Tuesday, October 6th. Finally, Wells Fargo & Company increased their target price on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Fifteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $1,026.18.

Insider Transactions at McKesson

In related news, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Francisco Fraga sold 650 shares of the company’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total transaction of $716,924.00. Following the sale, the executive vice president directly owned 4,414 shares of the company’s stock, valued at approximately $4,868,465.44. This trade represents a 12.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,462 shares of company stock valued at $2,511,106 over the last 90 days. Corporate insiders own 0.06% of the company’s stock.

McKesson Stock Performance

Shares of NYSE:MCK opened at $1,060.79 on Friday. The stock has a 50-day simple moving average of $938.13 and a 200-day simple moving average of $868.12. The stock has a market capitalization of $122.48 billion, a P/E ratio of 27.28, a PEG ratio of 2.08 and a beta of 0.27. McKesson Corporation has a 1 year low of $723.68 and a 1 year high of $1,121.50.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating the consensus estimate of $10.72 by $0.96. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The firm had revenue of $110.96 billion for the quarter, compared to analyst estimates of $109.90 billion. During the same quarter last year, the firm posted $9.86 earnings per share. McKesson’s revenue for the quarter was up 7.5% compared to the same quarter last year. Analysts predict that McKesson Corporation will post 46.21 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Tuesday, December 1st will be given a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 9.67%.

McKesson Company Profile

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers.

The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care.

Founded in 1833, McKesson serves customers primarily in the United States and Canada.